Bridgeway Capital Management, LLC Icosavax, Inc. Transaction History

Bridgeway Capital Management, LLC

  • $4.76 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$4.89 - $10.57 $161,624 - $349,359
-33,052 Reduced 48.57%
35,000 $347,000
Q1 2023

May 15, 2023
SELL
$5.62 - $11.51 $112,400 - $230,200
-20,000 Reduced 22.71%
68,052 $394,000
Q4 2022

Feb 14, 2023
SELL
$2.32 - $10.97 $69,600 - $329,100
-30,000 Reduced 25.41%
88,052 $699,000
Q3 2022

Nov 14, 2022
BUY
$3.09 - $9.21 $364,780 - $1.09 Million
118,052 New
118,052 $373,000

Others Institutions Holding ICVX

# of Institutions
2
Shares Held
1.37M
Call Options Held
0
Put Options Held
0
View Full List

About Icosavax, Inc.

ICVX Quotes by TradingView
  • Ticker ICVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,885,200
  • Description
  • Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...
More about ICVX
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email